These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 31658185)

  • 1. Brief Report: Yield and Efficiency of Intensified Tuberculosis Case-Finding Algorithms in 2 High-Risk HIV Subgroups in Uganda.
    Semitala FC; Cattamanchi A; Andama A; Atuhumuza E; Katende J; Mwebe S; Asege L; Nakaye M; Kamya MR; Yoon C
    J Acquir Immune Defic Syndr; 2019 Dec; 82(4):416-420. PubMed ID: 31658185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yield and Efficiency of Novel Intensified Tuberculosis Case-Finding Algorithms for People Living with HIV.
    Yoon C; Semitala FC; Asege L; Katende J; Mwebe S; Andama AO; Atuhumuza E; Nakaye M; Armstrong DT; Dowdy DW; McCulloch CE; Kamya M; Cattamanchi A
    Am J Respir Crit Care Med; 2019 Mar; 199(5):643-650. PubMed ID: 30192649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study.
    Yoon C; Semitala FC; Atuhumuza E; Katende J; Mwebe S; Asege L; Armstrong DT; Andama AO; Dowdy DW; Davis JL; Huang L; Kamya M; Cattamanchi A
    Lancet Infect Dis; 2017 Dec; 17(12):1285-1292. PubMed ID: 28847636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hematocrit on point-of-care C-reactive protein-based tuberculosis screening among people living with HIV initiating antiretroviral therapy in Uganda.
    Mwebe SZ; Yoon C; Asege L; Nakaye M; Katende J; Andama A; Cattamanchi A; Semitala FC
    Diagn Microbiol Infect Dis; 2021 Mar; 99(3):115281. PubMed ID: 33453673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care C-reactive protein testing to facilitate implementation of isoniazid preventive therapy for people living with HIV.
    Yoon C; Davis JL; Huang L; Muzoora C; Byakwaga H; Scibetta C; Bangsberg DR; Nahid P; Semitala FC; Hunt PW; Martin JN; Cattamanchi A
    J Acquir Immune Defic Syndr; 2014 Apr; 65(5):551-6. PubMed ID: 24346636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.
    Huerga H; Mathabire Rucker SC; Cossa L; Bastard M; Amoros I; Manhiça I; Mbendera K; Telnov A; Szumilin E; Sanchez-Padilla E; Molfino L
    PLoS Med; 2019 Apr; 16(4):e1002792. PubMed ID: 31039161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV.
    Boyles TH; Griesel R; Stewart A; Mendelson M; Maartens G
    Int J Infect Dis; 2018 Oct; 75():67-73. PubMed ID: 30125689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral clinic versus centralized laboratory-based Xpert MTB/RIF performance: Experience gained from a pragmatic, stepped-wedge trial in Botswana.
    Agizew T; Boyd R; Ndwapi N; Auld A; Basotli J; Nyirenda S; Tedla Z; Mathoma A; Mathebula U; Lesedi C; Pals S; Date A; Alexander H; Kuebrich T; Finlay A
    PLoS One; 2017; 12(8):e0183237. PubMed ID: 28817643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The patient impact of point-of-care vs. laboratory placement of Xpert(®) MTB/RIF.
    Hanrahan CF; Clouse K; Bassett J; Mutunga L; Selibas K; Stevens W; Scott L; Sanne I; Van Rie A
    Int J Tuberc Lung Dis; 2015 Jul; 19(7):811-6. PubMed ID: 26056107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point-of-care C-reactive protein and risk of early mortality among adults initiating antiretroviral therapy.
    Chaisson LH; Semitala FC; Asege L; Mwebe S; Katende J; Nakaye M; Andama AO; Marquez C; Atuhumuza E; Kamya M; Cattamanchi A; Yoon C
    AIDS; 2019 Apr; 33(5):895-902. PubMed ID: 30649057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana's Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortality.
    Auld AF; Agizew T; Pals S; Finlay A; Ndwapi N; Boyd R; Alexander H; Mathoma A; Basotli J; Gwebe-Nyirenda S; Shepherd J; Ellerbrock TV; Date A
    BMC Infect Dis; 2016 Oct; 16(1):606. PubMed ID: 27782821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
    Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
    BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
    Orikiriza P; Nansumba M; Nyehangane D; Bastard M; Mugisha IT; Nansera D; Mwanga-Amumpaire J; Boum Y; Kumbakumba E; Bonnet M
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1465-1473. PubMed ID: 29740714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tuberculosis screening and retention interventions on early antiretroviral therapy mortality in Botswana: a stepped-wedge cluster randomized trial.
    Auld AF; Agizew T; Mathoma A; Boyd R; Date A; Pals SL; Serumola C; Mathebula U; Alexander H; Ellerbrock TV; Rankgoane-Pono G; Pono P; Shepherd JC; Fielding K; Grant AD; Finlay A
    BMC Med; 2020 Feb; 18(1):19. PubMed ID: 32041583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparision of the yield of three tuberculosis screening modalities among people living with HIV: a retrospective quasi-experiemental study.
    Kakinda M; Matovu JK; Obuku EA
    BMC Public Health; 2016 Oct; 16(1):1080. PubMed ID: 27737681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incremental Yield of Including Determine-TB LAM Assay in Diagnostic Algorithms for Hospitalized and Ambulatory HIV-Positive Patients in Kenya.
    Huerga H; Ferlazzo G; Bevilacqua P; Kirubi B; Ardizzoni E; Wanjala S; Sitienei J; Bonnet M
    PLoS One; 2017; 12(1):e0170976. PubMed ID: 28125693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Yield of Different Diagnostic Tests for Tuberculosis among People Living with HIV in Western Kenya.
    Cavanaugh JS; Modi S; Musau S; McCarthy K; Alexander H; Burmen B; Heilig CM; Shiraishi RW; Cain K
    PLoS One; 2016; 11(3):e0152364. PubMed ID: 27023213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing Tuberculosis Diagnostic Yield in Smear/Culture and Xpert® MTB/RIF-Based Algorithms Using a Non-Randomised Stepped-Wedge Design.
    Naidoo P; Dunbar R; Lombard C; du Toit E; Caldwell J; Detjen A; Squire SB; Enarson DA; Beyers N
    PLoS One; 2016; 11(3):e0150487. PubMed ID: 26930400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria.
    Agizew T; Boyd R; Mathebula U; Mathoma A; Basotli J; Serumola C; Pals S; Finlay A; Lekone P; Rankgoane-Pono G; Tlhakanelo T; Chihota V; Auld AF
    PLoS One; 2020; 15(6):e0234646. PubMed ID: 32530972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.